A “Sherlock” reunion is happening in the Marvel Cinematic Universe (MCU) as Benedict Cumberbatch‘s “Sherlock” co-star, Martin Freeman, is heading to the MCU for a potentially major role in “Captain America: Civil War”.
Marvel Studios confirmed this piece of good news today by announcing that Freeman is officially part of the Marvel family.
Freeman is best known for his roles as Bilbo Baggins in “The Hobbit” trilogy and as Tim in “The Office”. The English actor earned both Primetime Emmy Award and BAFTA Award for his portrayal of Doctor John Watson in “Sherlock”. He also received many other award nominations for his role as Lester Nygaard in “Fargo”.
Due to his versatility as an actor, Marvel Studios president Kevin Feige said, “Martin’s range from the dramatic to the comedic has consistently impressed us. We couldn’t be more honoured or excited to have such a talented actor join the Marvel Cinematic Universe.”
No details regarding Freeman’s role were revealed and the studio made his character even more vague after announcing that German-Spanish actor Daniel Brühl will be portraying a villain called Baron Zemo. If Freeman is going to portray an ally to Avengers, he could be teaming up with Cumberbatch again in the MCU. Cumberbatch, who is set to portray Doctor Strange, previously worked with Freeman in “Sherlock” and “The Hobbit”.
Sebastian Stan and Anthony Mackie will reprise their respective roles as The Winter Soldier and The Falcon in the movie, alongside Samuel L. Jackson and Scarlett Johansson. Chadwick Boseman will be introduced as Black Panther before his solo movie arrives.
Slated for release on 6th May 2016, “Captain America: Civl War” is a follow-up to Marvel’s “Captain America: The Winter Soldier”, which will be directed by Joe and Anthony Russo. It will once again star Robert Downey Jr as Iron Man and Chris Evans as Captain America.
The story is expected to revolve around the entire MCU as the superheroes are divided into 2 sides; one that supports the government’s registration program for superhumans and one that opposes the program.